Get startedLog in
    Picture of Viracta Therapeutics logo

    VIRX — Viracta Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Viracta Therapeutics Initiates Phase 1B/2 Trial In Epstein-Barr Virus-Positive (Ebv+) Solid Tumors

    Picture of Viracta Therapeutics logoViracta Therapeutics
    06/10/2021 13:18
    Oct 6 (Reuters) - Viracta Therapeutics Inc  VIRX.O :
    * VIRACTA THERAPEUTICS INITIATES PHASE 1B/2 TRIAL IN
EPSTEIN-BARR
VIRUS-POSITIVE (EBV+) SOLID TUMORS

Source text for Eikon:  ID:nPn8lMFH2a 
Further company coverage:  VIRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Viracta Therapeutics

    See all news